Summary | The Swiss pharmaceutical manufacturer Novartis has
obtained approval from the Ministry of Commerce to acquire an
85 percent stake in Zhejiang-based Tianyuan Bio-Pharmaceutical
Co Ltd (TBP), in a deal indicating a growing interest in the
human vaccine sector in China.
chinadaily.com.cn | 16 April 2015